NuraLogix Announces ‘Holy Grail’ of Blood Pressure Measurement
Researchers at NuraLogix, a global leader in Health Tech AI, announced that they have achieved the ‘Holy Grail’ of contactless blood pressure (BP) measurement using the company’s TOI based Anura app!
What is the Holy Grail of contactless blood pressure measurement? It’s when you can measure your blood pressure with an accuracy corresponding to a standard deviation of error of less than 8mmHg,” stated NuraLogix CEO and co-founder Marzio Pozzuoli. “This represents a breakthrough achievement by the research team at NuraLogix and sets a new industry benchmark.” Even more importantly this level of accuracy was achieved without physiological calibration of the measuring device (i.e. Anura) to the individual having their blood pressure measured.
Recommended AI: Positon Launches PosiVault, an AI-Powered SaaS Application for Programmatic M&A
Previously in 2020, NuraLogix was the first to achieve this level of accuracy for contactless video camera based BP devices with N=85 subjects which is the minimum requirement according ISO 81060-2:2018 the standard used by all BP devices to measure accuracy. The current testing was done on N=554 subjects which represents a new benchmark and that the technology is more generalizable to a broader population.
It is the company’s intention to publish results as part of a planned series of clinical trials in the U.S and other countries in 2023.
NuraLogix are the creators of the world’s first contactless blood pressure measurement technology. The company’s patented technology can measure 30+ health and wellness parameters using Transdermal Optical Imaging (TOI), a patented technique developed by the company in which a conventional video camera is used to extract facial blood flow information from the human face. This is demonstrated in the company’s ground-breaking app Anura and Anura Lite.
Recommended AI: Himax Partners with Novatek to Unveil Industry Leading Ultralow Power Pre-Roll AI Solution for Battery Surveillance Camera
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.